Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension

NCT ID: NCT03388476

Last Updated: 2022-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-02

Study Completion Date

2035-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The disease pulmonary hypertension is due to a remodeling of the lung vessels which results in a change of the exhaled air. This change is measurable with a so called capnograph. The investigators want to measure the breath from patients with and without pulmonary hypertension to detect a cut-off value for the diagnosis pulmonary hypertension.

Patients which have the probably diagnosis pulmonary hypertension and are older than 18 years are investigated. This patients will get an right heart catheterization and a measurement from their exhaled air.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension, Pulmonary Hypertension;Pulmonary;Primary Chronic Thromboembolic Pulmonary Hypertension Vascular Diseases Lung Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Suspicion of pulmonary hypertension

At Patients with suspicion of pulmonary hypertension, which get a right heart catheterization, in the context of the study the exhaled air, precious the endtidal carbon dioxide (CO2), before or after the right heart catheterization will be measured through capnography.

Capnography

Intervention Type DIAGNOSTIC_TEST

Measuring of the exhaled air, especially endtidal co2, through capnography.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Capnography

Measuring of the exhaled air, especially endtidal co2, through capnography.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age \> 18 years, suspicion of pulmonary hypertension, planned or accomplished right heart catheterization

Exclusion Criteria

none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Giessen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sophie Herbst

Study Chair: Ghofrani H. Ardeschir, Prof. Dr. University of Giessen

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Henning Gall, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Clinic Giessen and Marburg - Campus Giessen

Werner Seeger, Prof.

Role: STUDY_DIRECTOR

University Clinic Giessen and Marburg

Ardeschir Ghofrani, Prof.

Role: STUDY_DIRECTOR

University Clinic Giessen and Marburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Clinic Giessen and Marburg

Giessen, Hesse, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Chest. 2011 Nov;140(5):1267-1273. doi: 10.1378/chest.11-0155. Epub 2011 May 26.

Reference Type BACKGROUND
PMID: 21622547 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DRKS00013589

Identifier Type: REGISTRY

Identifier Source: secondary_id

AZ 156/17

Identifier Type: OTHER

Identifier Source: secondary_id

AZ 156/17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.